Sustiva - Newsfeeds

Merck funds ARVS, Moeti applauds!: Merck donates its ARV medicines CRIXIVAN(R) (indinavir sulfate), STOCRIN(R) (efavirenz), to Botswana's national treatment program and will continue to do so for the duration of the partnership's second phase through ...
Unavailability of key HIV drug blown out of proportion: Health Minister Dr. Leslie Ramsammy said people are “blowing up” the unavailability of the antiretroviral drug Efavirenz and he has assured that it will be in the country. The shipment was expected “at midnight ...
One key HIV drug unavailable: Guyana is currently out of the antiretroviral drug, Efavirenz, which is part of this country’s first-line treatment programme but a shipment is expected by Thursday according to Health Minister, Dr. Leslie Ramsammy ...
AFRICA: Drug-resistant HIV threat looming: ... drug resistance had resistance to a class of ARVs called non-nucleoside reverse transcriptase inhibitors (NNRTIs), which includes nevirapine as well as efavirenz - both widely used in Africa in first-line ARV ...
Milton resident: No more flouride: Fluoride is both an organic and inorganic compound that range from potent toxins such as sarin to life-saving pharmaceuticals such as efavirenz. Water fluoridation, which Chase is questioning, is a practice that ...
Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily ...: efavirenz in the percentage of patients achieving an undetectable viral load (less than 50 copies/mL) at week 48 (with a maximum allowable difference of 12 percent).5 The studies showed that TMC278 demonstrated ...
Fitch Affirms Bristol-Myers Squibb Co.'s 'A+' IDR; Outlook Negative: including around one-third of the Sustiva franchise. The company's diversified and promising late-stage R&D portfolio, if commercialized, is not anticipated to fully offset the expected rapid decline in revenues in ...
Bristol-Myers Squibb to Buy Zymogenetics for $885 Million: Reyataz and Sustiva for HIV, Sprycel for cancer, and Onglyza for diabetes. However the company is looking for ways to shore up its growth in the coming years. The patents supporting Plavix will expire in 2012,

Thailand to extend enforcement of compulsory licensing for 2 AIDS drugs: BANGKOK, June 14 (Xinhua) -- Thailand's National Health Security Office (NHSO)'s board Monday asked the Public Health Ministry to extend enforcement of compulsory licensing for two drugs for AIDS treatment -- Efavirenz ...
Drug Tests Often Trigger False Positives: The quinolone antibiotic drugs can trigger false positives for opioids, and the HIV medication Sustiva can show up as marijuana use, Smith says. On the other hand, just being in the room with someone who is smoking ...
Research and Markets: Brazil's Generic Medicines Continue to grow at a ...: ... Brazil allows compulsory licensing in cases of national emergency or public interest; Brazil issued its first compulsory licence in May 2007, for Merck Sharp & Dohme's Stocrin (efavirenz). Rising patient numbers, increasing resistance levels ...
AIDS Drugs Should Be Used to Help Prevent Infections, WHO Says: s Sustiva along with Gilead Sciences Inc.’s Truvada, can keep viral levels so low that HIV is undetectable by conventional means. That limits the patient’s ability to spread the disease. ‘Test and Treat’ The so-called “test and treat ...
Mylan's Matrix Receives First and Only Tentative FDA Approval Under ...: Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for a fixed-dose combination (FDC) of Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Tablets ...
Strong sales boost Bristol-Myers 2Q profit: Sales of psychiatric drug Abilify jumped 22 percent to $643 million and HIV drug Sustiva was up 11 percent to $312 million. But Bristol's sales of cancer drug Erbitux, which it markets jointly with Eli Lilly&Co., fell 12 percent to $173 million. ...
5 Stocks Making Cash: A combination of Gilead's Truvada and Bristol-Myers Squibb 's (NYSE: BMY) Sustiva, the antiretroviral Atripla is the most prescribed treatment for HIV, with 33% of all treated patients on the regimen. Sales jumped 60% year over year last quarter and ...
Matrix Labs gets tentative USDFA nod for HIV drugs: Efavirenz (brand names Sustiva and Stocrin) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1. Emtricitabine ...

Want to contact a Sustiva lawyer in District of Columbia? ...Get a free case evaluation from one of our Sustiva lawyers in District of Columbia now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need A Sustiva Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Sustiva Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Sustiva Information

Click to View Our Legal Resources

Want to contact a Sustiva lawyer in District of Columbia? ...Get a free case evaluation from one of our Sustiva lawyers in District of Columbia now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120128-054518

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Sustiva Click to select a Legal Issue

Close (x)

Find Legal Help for Your Sustiva Case - Submit Your Information Below

Do you need legal assistance with your Sustiva case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Sustiva Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.